InvestorsHub Logo
Followers 144
Posts 27707
Boards Moderated 3
Alias Born 02/07/2004

Re: The Stock Reader post# 1854

Tuesday, 04/05/2022 8:24:54 AM

Tuesday, April 05, 2022 8:24:54 AM

Post# of 2049
I do not understand the reason of
this PR at all.
Who needs a

'Potential Complementary
Product to its Phase III Oral Psoriasis Drug



Especially when Phase III is not yet approved?!
Very strange PR to say the least.
Small wonder the stock is not flying. I wager
the stock will end in the red by EOD.

Who can enlighten me?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CANF News